History
2020
-
01
EGglue™, topical skin adhesive is approved - MFDS Class 3
2019
-
08
Soft Fix PLUS™, fixation device is approved - MDFS Class 1
06Manufacturing facility relocated in Dongtan for the expansion and renewed KGMP certification
03Specially controlled embolization agent (IPZA™) for MSK chronic pain treatment development started
2018
-
01
Launched EGgel™/EGgel S PLUS™ in the overseas market
2017
-
12
EGbead™, intravascular embolization agent is approved - MFDS Class 3
Varicose vein treatment device (EGpresto™) development started09Medical adhesive (EGglue™ , EGglue elasto™) development started
05Launched EGgel S PLUS™ in the domestic market
04Received ISO 13485:2016(quality management system) certification
2016
-
10
Launched EGgel™ in the domestic market
06EGgel™, intravascular embolization agent is approved - MFDS Class 3
01Completed Sangdaewon-dong manufacturing facility and received KGMP(Korea Good Manufacturing Practice) certification
2013
-
11
GluLiner™, continuous glucose monitoring system is approved - MFDS Class 3
07Registered as medical device manufacturing company
2011
-
12
Established ENGAIN Co.,Ltd.